e-learning
resources
ERJ
2003
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Regular salbutamol use increases CXCL8 responses in asthma: relationship to the eosinophil response
Gordon J.R., Swystun V.A., Li F., Zhang X., Davis B.E., Hull P., Cockcroft D.W.
Source:
Eur Respir J 2003; 22: 118-126
Journal Issue:
July
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Gordon J.R., Swystun V.A., Li F., Zhang X., Davis B.E., Hull P., Cockcroft D.W.. Regular salbutamol use increases CXCL8 responses in asthma: relationship to the eosinophil response. Eur Respir J 2003; 22: 118-126
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Mechanisms of noneosinophilic asthma
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007
Possible anti-inflammatory effect of salmeterol against interleukin-8 and neutrophil activation in asthma in vivo
Source: Eur Respir J 2003; 21: 994-999
Year: 2003
The effect of fluticasone on the airway inflammatory response to organic dust
Source: Eur Respir J 2004; 24 : 587-593
Year: 2004
Local application of FTY720 to the lung abrogates experimental asthma by altering myeloid dendritic cell function
Source: Annual Congress 2006 - Towards understanding the pathogenesis of asthma
Year: 2006
Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids
Source: Eur Respir J 2002; 20: 1364-1369
Year: 2002
Effects of salmeterol/fluticasone propionate (SFC) on airway inflammation in induced sputum in COPD
Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD
Year: 2005
Single-dose desloratadine and montelukast and allergen-induced late airway responses
Source: Eur Respir J 2009; 33: 1302-1308
Year: 2009
Airway eosinophilia is not related to clinical and functional findings in a large group of severe refractory asthmatics
Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers
vs
induced sputum
Year: 2006
One year monitoring of children with bronchial asthma and other allergic diseases treated with inhaled corticosteroids vs cromoglycates with serum ECP (S-ECP), FEV1, total IgE and blood eosinophil count - the influence of different therapy
Source: Eur Respir J 2002; 20: Suppl. 38, 432s
Year: 2002
Treatment: how does inflammatory phenotype influence response to treatment in airway disease?
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007
Ciclesonide 80 μg once daily reduces early and late asthmatic reaction, sputum eosinophils and serum ECP in asthma patients challenged with allergens
Source: Eur Respir J 2005; 26: Suppl. 49, 254s
Year: 2005
Reduced late asthmatic response by repeated low-dose allergen exposure
Source: Eur Respir J 2001; 17: 872-880
Year: 2001
Sputum eosinophil counts in a large population of mild-to-moderate asthmatics: distribution, relationship with methacholine bronchial responsiveness and influence of a regular treatment with low doses of inhaled corticosteroids
Source: Eur Respir J 2001; 18: Suppl. 33, 531s
Year: 2001
Reduced eosinophil apoptosis in induced sputum correlates with asthma severity
Source: Eur Respir J 2003; 22: 484-490
Year: 2003
Cysteinyl-leukotriene levels in sputum differentiate asthma from rhinitis patients with or without bronchial hyperresponsiveness
Source: Annual Congress 2007 - Asthma subphenotypes
Year: 2007
Oophorectomy decreases airway responsiveness but not eosinophilia in an ovalbumin sensitization murine model of allergy
Source: Annual Congress 2006 - Cell biology of asthma and COPD
Year: 2006
Eosinophilic inflammation in sputum of poorly controlled asthmatics
Source: Eur Respir J 2002; 20: 1370-1377
Year: 2002
Inhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459
Source: Eur Respir J 2013; 41: 46-52
Year: 2013
Correlation of plasma IL-5 with sputum and blood eosinophils and ECP following a single nasal allergen challenge in non-asthmatic subjects with seasonal allergic rhinitis
Source: Eur Respir J 2002; 20: Suppl. 38, 217s
Year: 2002
Does sputum eosinophil counts predict the response to inhaled corticosteroids in terms of methacholine bronchial responsiveness in steroid naive asthmatics?
Source: Eur Respir J 2001; 18: Suppl. 33, 336s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept